Brief: Annexin Secures Financing Through Bridge Loan Facility, Plans Rights Issue
April 13 (Reuters) - Annexin Pharmaceuticals AB (publ) ANNX.ST: ANNEXIN SECURES FINANCING THROUGH BRIDGE LOAN FACILITY AND PLANS A RIGHTS ISSUE OF APPROXIMATELY SEK 20 MILLION DURING THE SUMMER OF 2026 SECURES BRIDGE FINANCING OF ABOUT SEK 4 MILLION PLANS RIGHTS ISSUE OF ABOUT SEK 20 MILLION IN SUMMER 2026 Source text: ID:nMFN8pvTFn Further company coverage: ANNX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Resolves Rights Issue Of About SEK 20 Mln
Brief: Annexin Receives German Approval For ANXV Clinical Trial
Brief: Annexin Secures Financing Through Bridge Loan Facility, Plans Rights Issue
Brief: Annexin Pharmaceuticals Q4 Net Loss At SEK 10.5 Mln
Brief: Annexin Gets Approval For Phase 2A Study In Diabetic Retinopathy, RVO